SEC Form 4 · accession 0001203311-15-000058
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Gryska
Director
Period of report
Nov 5, 2015
Accepted (ET)
Nov 5, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 5, 2015 | S | 10,000 | $43.5737 | D | 23,950 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.